+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 2
Age: 4Weeks - 2Years
All Genders
ID07770464

Role of Montelukast in Treating Acute Bronchiolitis in Hospitalized Children A Randomized Study Comparing Montelukast to Placebo with Standard Care

Led by Pakistan Institute of Medical Sciences · Updated on 2026-08-18

60

Participants Needed

1

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating the use of Montelukast in treating acute bronchiolitis in children admitted to the hospital. The study aims to see if Montelukast can shorten hospital stay duration and improve symptoms compared to a placebo. This is a Phase 2 randomized clinical trial focused on treatment outcomes for young children with this condition. Participants will be randomly assigned to one of two groups. One group will receive Montelukast 4 mg sachet orally once daily at night along with standard supportive care. The other group will receive placebo sugar granules on the same schedule plus standard care. The treatment period starts at hospital admission and continues for at least 72 hours, with follow-up until discharge. During the study, participants will be monitored for changes in clinical severity scores from admission up to 72 hours after beginning treatment. Researchers will also track the total length of hospital stay from admission to discharge, up to 7 days. Safety and symptom improvements will be assessed throughout the hospitalization period, with close observation of respiratory status and supportive care.

CONDITIONS

Brief Title

Evaluating The Role Of Montelukast In Management Of Acute Bronchiolitis

Research Team

D

Dr Haniyah Anwar, M.B.B.S

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here